Cell line name |
CB-F7 |
Synonyms |
CBF-7; CBF7 |
Accession |
CVCL_9V08 |
Resource Identification Initiative |
To cite this cell line use: CB-F7 (RRID:CVCL_9V08) |
Comments |
Group: Hybridoma fusion partner cell line. Selected for resistance to: ChEBI; CHEBI:472805; Ouabain. |
Species of origin |
Homo sapiens (Human) (NCBI Taxonomy: 9606)
Mus musculus (Mouse)
(NCBI Taxonomy: 10090) |
Hierarchy |
Parent: CVCL_4032 (P3X63Ag8.653) Children:
|
Category |
Hybrid cell line |
Publications | PubMed=2828478; DOI=10.1016/0022-1759(88)90206-2 Grunow R., Jahn S., Porstmann T., Kiessig S.S., Steinkellner H., Steindl F., Mattanovich D., Gurtler L., Deinhardt F.W., Katinger H., von Baehr R. The high efficiency, human B cell immortalizing heteromyeloma CB-F7 Production of human monoclonal antibodies to human immunodeficiency virus. J. Immunol. Methods 106:257-265(1988) PubMed=7492749; DOI=10.3233/HAB-1995-6201 Delvig A.A., Koumare B., Glaser R.W., Wang J.-F., Jahn S., Achtman M. Comparison of three human-murine heteromyeloma cell lines for formation of human hybridomas after electrofusion with human peripheral blood lymphocytes from meningococcal cases and carriers. Hum. Antibodies Hybridomas 6:42-46(1995) PubMed=9708833; DOI=10.1089/hyb.1998.17.299 Niedbala W.G., Stott D.I. A comparison of three methods for production of human hybridomas secreting autoantibodies. Hybridoma 17:299-304(1998) |
Cross-references |
Encyclopedic resources |
Wikidata; Q54808639
|
Entry history |
Entry creation | 23-Feb-2016 |
Last entry update | 21-Mar-2023 |
Version number | 6 |
---|